These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20173694)

  • 21. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
    Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
    J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007).
    El Mallakh RS; Vieta E; Rollin L; Marcus R; Carson WH; McQuade R
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):776-83. PubMed ID: 20728318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.
    Coley KC; Scipio TM; Ruby C; Lenze EJ; Fabian TJ
    J Psychiatr Pract; 2009 Mar; 15(2):150-3. PubMed ID: 19339850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of high-dose aripiprazole for treatment-resistant schizoaffective disorder: a case report.
    Saatcioglu O; Gumus S; Kamberyan K; Yanik M
    Psychopharmacol Bull; 2010; 43(4):70-2. PubMed ID: 21240152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of aripiprazole on patients with at-risk mental state and subjective well-being].
    Kobayashi T
    Seishin Shinkeigaku Zasshi; 2010; 112(11):1156-63. PubMed ID: 21351695
    [No Abstract]   [Full Text] [Related]  

  • 26. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
    Yatham LN; Fallu A; Binder CE
    Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder.
    Vieta E; Suppes T; Ekholm B; Udd M; Gustafsson U
    J Affect Disord; 2012 Dec; 142(1-3):36-44. PubMed ID: 23062763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aripiprazole and depression in schizoaffective disorder.
    Errico JR; Yates WR
    Am J Psychiatry; 2005 Mar; 162(3):626-7. PubMed ID: 15741489
    [No Abstract]   [Full Text] [Related]  

  • 30. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.
    Woo YS; Bahk WM; Chung MY; Kim DH; Yoon BH; Lee JH; Ahn YM; Chung SK; Kim JG; Lee KH; Paik KC
    Hum Psychopharmacol; 2011 Dec; 26(8):543-53. PubMed ID: 22134973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [No rebound psychosis in a case of switching from clozapine to quetiapine].
    Walther S; Baciu D
    Psychiatr Prax; 2006 Mar; 33(2):93-4. PubMed ID: 16502388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
    Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manic episode during treatment with aripiprazole.
    Padala PR; Wengel SP; Petty F
    Am J Psychiatry; 2007 Jan; 164(1):172-3. PubMed ID: 17202565
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.
    Strakowski SM; Keck PE; Wong YW; Thyrum PT; Yeh C
    J Clin Psychopharmacol; 2002 Apr; 22(2):201-5. PubMed ID: 11910267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Restless legs syndrome associated with the combined use of quetiapine and venlafaxine.
    Michopoulos I; Ferentinos P; Oulis P; Gournellis R
    J Clin Psychopharmacol; 2014 Feb; 34(1):159-61. PubMed ID: 24135842
    [No Abstract]   [Full Text] [Related]  

  • 36. Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study.
    Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen HM; Isometsä E
    J Affect Disord; 2010 Feb; 121(1-2):116-26. PubMed ID: 19497622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quetiapine dosage across diagnostic categories.
    Khazaal Y; Chatton A; Khan R; Zullino D
    Psychiatr Q; 2009 Mar; 80(1):17-22. PubMed ID: 19142727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aripiprazole in the treatment of bipolar disorder in children and adolescents.
    Durkin JP
    J Child Adolesc Psychopharmacol; 2004; 14(4):505-6. PubMed ID: 15662141
    [No Abstract]   [Full Text] [Related]  

  • 39. Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006-2010).
    Jing Y; Guo Z; Kalsekar I; Forbes RA; Hebden T; Thase ME
    Int Clin Psychopharmacol; 2013 Mar; 28(2):87-90. PubMed ID: 23262644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting.
    Ketter TA; Brooks JO; Hoblyn JC; Holland AA; Nam JY; Culver JL; Marsh WK; Bonner JC
    J Psychiatr Res; 2010 Oct; 44(14):921-9. PubMed ID: 20378127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.